SU9518 Inhibits Proliferative Vitreoretinopathy (PVR) in a Rabbit Model

被引：0
|
作者：
Velez, G. [1 ,2 ]
Kazlauskas, A. [1 ,2 ]
Young, M. [1 ,2 ]
机构：
[1] Schepens Eye Res Inst, Boston, MA USA
[2] Harvard Med Sch, Ophthalmol, Boston, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
proliferative vitreoretinopathy; drug toxicity/drug effects; growth factors/growth factor receptors;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6086
引用
收藏
页数：2
相关论文
共 50 条
  • [21] HYPERTHERMIA REDUCES THE OCCURRENCE OF PROLIFERATIVE VITREORETINOPATHY IN A RABBIT MODEL
    YOSHIMURA, N
    KURIYAMA, S
    OHUCHI, T
    TAKEMURA, M
    HONDA, Y
    HIRAOKA, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (02) : 404 - 409
  • [22] Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model
    Heffer, Alison M.
    Wang, Victor
    Libby, Richard T.
    Feldon, Steven E.
    Woeller, Collynn F.
    Kuriyan, Ajay E.
    PLOS ONE, 2020, 15 (12):
  • [23] Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis
    Yamasaki, Y
    Miyoshi, K
    Oda, N
    Watanabe, M
    Miyake, H
    Chan, J
    Wang, XY
    Sun, L
    Tang, C
    McMahon, G
    Lipson, KE
    CIRCULATION RESEARCH, 2001, 88 (06) : 630 - 636
  • [24] EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY (PVR) IN THE VITRECTOMIZED EYE - EFFECT OF SILICONE OIL
    LEAN, JS
    VANDERZEE, WAM
    RYAN, SJ
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1984, 68 (05) : 332 - 335
  • [25] Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
    Mostafa, I.
    Al-Zubaidy, M.
    Ghareeb, A.
    Song, A.
    Mehta, A.
    Murphy, D.
    Sadiq, S.
    Tzoumas, N.
    Steel, D. H.
    EYE, 2022, 36 (02) : 352 - 353
  • [26] A simulacrum of proliferative vitreoretinopathy (PVR): development and proteomics-based validation of an in vitro model
    Sumit Sharma
    Amit Kumar Thakur
    Maryada Sharma
    Deeksha Katoch
    Reema Bansal
    Ramandeep Singh
    Mangat R. Dogra
    Manni Luthra-Guptasarma
    Journal of Proteins and Proteomics, 2024, 15 (2) : 105 - 118
  • [27] The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)
    Khaled Nassar
    Julia Lüke
    Matthias Lüke
    Mahmoud Kamal
    Effat Abd El-Nabi
    Mahmoud Soliman
    Martin Rohrbach
    Salvatore Grisanti
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 1649 - 1660
  • [28] Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
    I. Mostafa
    M. Al-Zubaidy
    A. Ghareeb
    A. Song
    A. Mehta
    D. Murphy
    S. Sadiq
    N. Tzoumas
    D. H. Steel
    Eye, 2022, 36 : 352 - 353
  • [29] Thiotepa: Possible use in the treatment and prevention of proliferative vitreoretinopathy (PVR)
    Kon, CH
    Occleston, NL
    Foss, AJ
    Sheridan, C
    Khaw, PT
    Aylward, GW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1805 - 1805
  • [30] p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model
    Zhang, Qi
    Guo, Yangchen
    Kang, Moorim
    Lin, Wei-Hsiang
    Wu, Jian-Cheng
    Yu, Ying
    Li, Long-Cheng
    Sang, Aimin
    PLOS ONE, 2023, 18 (02):
12345